Jonathan Smith
20Patents
9h-index
22Co-inventors
75Inventor score
Filing activity: Jan 31, 1992 → Jun 3, 2019
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5843701A | Systematic polypeptide evolution by reverse translation | Chemistry; Metallurgy | 89 | Expired |
| US6376190B1 | Modified SELEX processes without purified protein | Chemistry; Metallurgy | 71 | Expired |
| US6194550A | Systematic polypeptide evolution by reverse translation | Chemistry; Metallurgy | 63 | Expired |
| US6458539B1 | Photoselection of nucleic acid ligands | Chemistry; Metallurgy | 48 | Expired |
| US6506887B1 | Conditional-selex | Chemistry; Metallurgy | 22 | Expired |
| US6730482B2 | Modified SELEX processes without purified protein | Chemistry; Metallurgy | 21 | Expired |
| US6387620B1 | Transcription-free selex | Chemistry; Metallurgy | 20 | Expired |
| US8216780B2 | Method for enhanced sensitivity in bacteriophage-based diagnostic assays | Physics | 14 | Active |
| US8455186B2 | Method of detection of microorganisms with enhanced bacteriophage amplification | Physics | 13 | Active |
| US8536117B2 | Oxidant resistant apolipoprotein A-1 and mimetic peptides | Human Necessities | 7 | Active |
| US8338110B2 | Risk markers for cardiovascular disease | Physics | 5 | Active |
| US6706482B2 | Conditional-selex | Chemistry; Metallurgy | 5 | Expired |
| US8071288B2 | Methods and reagents for detecting target binding by nucleic acid ligands | Physics | 5 | Active |
| US8143224B2 | Oxidant resistant apolipoprotein A-1 and mimetic peptides | Human Necessities | 3 | Active |
| US7781219B2 | Risk markers for cardiovascular disease | Physics | 3 | Active |
| US9051393B2 | Oxidant resistant apolipoprotein A-1 and mimetic peptides | Human Necessities | 2 | Active |
| US9005904B2 | Risk markers for cardiovascular disease | Physics | 1 | Active |
| US8722344B2 | Risk markers for cardiovascular disease | Physics | 1 | Active |
| US12292451B2 | ApoA1 exchange rate assays in serum | Physics | 0 | Active |
| US9522950B2 | Oxidant resistant apolipoprotein A-1 and mimetic peptides | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.